nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—Traumatic liver injury—Montelukast—chronic obstructive pulmonary disease	0.0408	0.0419	CcSEcCtD
Cefotaxime—Candida infection—Tiotropium—chronic obstructive pulmonary disease	0.0183	0.0189	CcSEcCtD
Cefotaxime—Liver injury—Montelukast—chronic obstructive pulmonary disease	0.018	0.0186	CcSEcCtD
Cefotaxime—Candida infection—Formoterol—chronic obstructive pulmonary disease	0.0148	0.0152	CcSEcCtD
Cefotaxime—Candida infection—Arformoterol—chronic obstructive pulmonary disease	0.0148	0.0152	CcSEcCtD
Cefotaxime—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.0124	0.0127	CcSEcCtD
Cefotaxime—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.0122	0.0125	CcSEcCtD
Cefotaxime—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.012	0.0124	CcSEcCtD
Cefotaxime—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.0112	0.0115	CcSEcCtD
Cefotaxime—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.0106	0.0109	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00992	0.0102	CcSEcCtD
Cefotaxime—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.00957	0.00984	CcSEcCtD
Cefotaxime—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.00957	0.00984	CcSEcCtD
Cefotaxime—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00943	0.0097	CcSEcCtD
Cefotaxime—Cefdinir—MPO—chronic obstructive pulmonary disease	0.00928	0.339	CrCbGaD
Cefotaxime—Cefaclor—MPO—chronic obstructive pulmonary disease	0.00919	0.336	CrCbGaD
Cefotaxime—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.00914	0.00939	CcSEcCtD
Cefotaxime—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00903	0.00929	CcSEcCtD
Cefotaxime—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00898	0.00923	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00891	0.00916	CcSEcCtD
Cefotaxime—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00866	0.0089	CcSEcCtD
Cefotaxime—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.00862	0.00886	CcSEcCtD
Cefotaxime—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00861	0.00886	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00842	0.00866	CcSEcCtD
Cefotaxime—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00828	0.00851	CcSEcCtD
Cefotaxime—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00803	0.00825	CcSEcCtD
Cefotaxime—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00798	0.00821	CcSEcCtD
Cefotaxime—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00771	0.00793	CcSEcCtD
Cefotaxime—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00767	0.00789	CcSEcCtD
Cefotaxime—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00762	0.00784	CcSEcCtD
Cefotaxime—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00746	0.00767	CcSEcCtD
Cefotaxime—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00739	0.0076	CcSEcCtD
Cefotaxime—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00735	0.00756	CcSEcCtD
Cefotaxime—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00727	0.00747	CcSEcCtD
Cefotaxime—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00721	0.00741	CcSEcCtD
Cefotaxime—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00715	0.00735	CcSEcCtD
Cefotaxime—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00695	0.00715	CcSEcCtD
Cefotaxime—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00695	0.00715	CcSEcCtD
Cefotaxime—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00693	0.00712	CcSEcCtD
Cefotaxime—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00687	0.00706	CcSEcCtD
Cefotaxime—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00686	0.00706	CcSEcCtD
Cefotaxime—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00683	0.00702	CcSEcCtD
Cefotaxime—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00674	0.00693	CcSEcCtD
Cefotaxime—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00657	0.00675	CcSEcCtD
Cefotaxime—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00647	0.00665	CcSEcCtD
Cefotaxime—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.00638	0.00656	CcSEcCtD
Cefotaxime—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00629	0.00646	CcSEcCtD
Cefotaxime—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00629	0.00646	CcSEcCtD
Cefotaxime—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00619	0.00637	CcSEcCtD
Cefotaxime—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00619	0.00637	CcSEcCtD
Cefotaxime—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00611	0.00628	CcSEcCtD
Cefotaxime—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00611	0.00628	CcSEcCtD
Cefotaxime—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00606	0.00624	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00594	0.00611	CcSEcCtD
Cefotaxime—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00594	0.0061	CcSEcCtD
Cefotaxime—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00585	0.00601	CcSEcCtD
Cefotaxime—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00577	0.00594	CcSEcCtD
Cefotaxime—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00577	0.00593	CcSEcCtD
Cefotaxime—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00575	0.00591	CcSEcCtD
Cefotaxime—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00574	0.00591	CcSEcCtD
Cefotaxime—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00574	0.00591	CcSEcCtD
Cefotaxime—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.0057	0.00586	CcSEcCtD
Cefotaxime—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.0057	0.00586	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.0056	0.00576	CcSEcCtD
Cefotaxime—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00553	0.00569	CcSEcCtD
Cefotaxime—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00553	0.00569	CcSEcCtD
Cefotaxime—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00544	0.0056	CcSEcCtD
Cefotaxime—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00542	0.00557	CcSEcCtD
Cefotaxime—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00542	0.00557	CcSEcCtD
Cefotaxime—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00538	0.00553	CcSEcCtD
Cefotaxime—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00535	0.0055	CcSEcCtD
Cefotaxime—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.0053	0.00545	CcSEcCtD
Cefotaxime—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00522	0.00537	CcSEcCtD
Cefotaxime—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00514	0.00529	CcSEcCtD
Cefotaxime—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00514	0.00528	CcSEcCtD
Cefotaxime—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00505	0.00519	CcSEcCtD
Cefotaxime—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00497	0.00511	CcSEcCtD
Cefotaxime—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00485	0.00498	CcSEcCtD
Cefotaxime—Pain—Formoterol—chronic obstructive pulmonary disease	0.00473	0.00486	CcSEcCtD
Cefotaxime—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00473	0.00486	CcSEcCtD
Cefotaxime—Pain—Montelukast—chronic obstructive pulmonary disease	0.00463	0.00476	CcSEcCtD
Cefotaxime—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00462	0.00475	CcSEcCtD
Cefotaxime—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00458	0.00471	CcSEcCtD
Cefotaxime—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00458	0.00471	CcSEcCtD
Cefotaxime—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00456	0.00469	CcSEcCtD
Cefotaxime—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00456	0.00469	CcSEcCtD
Cefotaxime—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00455	0.00468	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00452	0.00465	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00452	0.00465	CcSEcCtD
Cefotaxime—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00447	0.00459	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00443	0.00455	CcSEcCtD
Cefotaxime—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00439	0.00452	CcSEcCtD
Cefotaxime—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00439	0.00452	CcSEcCtD
Cefotaxime—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00437	0.00449	CcSEcCtD
Cefotaxime—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00437	0.00449	CcSEcCtD
Cefotaxime—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00437	0.00449	CcSEcCtD
Cefotaxime—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00437	0.00449	CcSEcCtD
Cefotaxime—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00436	0.00448	CcSEcCtD
Cefotaxime—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00432	0.00444	CcSEcCtD
Cefotaxime—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00432	0.00444	CcSEcCtD
Cefotaxime—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00432	0.00444	CcSEcCtD
Cefotaxime—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.0043	0.00442	CcSEcCtD
Cefotaxime—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.0043	0.00442	CcSEcCtD
Cefotaxime—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00429	0.00441	CcSEcCtD
Cefotaxime—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00428	0.0044	CcSEcCtD
Cefotaxime—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00428	0.0044	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00427	0.00439	CcSEcCtD
Cefotaxime—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00424	0.00436	CcSEcCtD
Cefotaxime—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00422	0.00433	CcSEcCtD
Cefotaxime—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00415	0.00427	CcSEcCtD
Cefotaxime—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00413	0.00424	CcSEcCtD
Cefotaxime—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00413	0.00424	CcSEcCtD
Cefotaxime—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00407	0.00419	CcSEcCtD
Cefotaxime—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00407	0.00419	CcSEcCtD
Cefotaxime—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00407	0.00418	CcSEcCtD
Cefotaxime—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00399	0.0041	CcSEcCtD
Cefotaxime—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00391	0.00402	CcSEcCtD
Cefotaxime—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00391	0.00402	CcSEcCtD
Cefotaxime—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00385	0.00396	CcSEcCtD
Cefotaxime—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00383	0.00394	CcSEcCtD
Cefotaxime—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00378	0.00389	CcSEcCtD
Cefotaxime—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00378	0.00389	CcSEcCtD
Cefotaxime—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00377	0.00387	CcSEcCtD
Cefotaxime—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00371	0.00381	CcSEcCtD
Cefotaxime—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00369	0.0038	CcSEcCtD
Cefotaxime—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00358	0.00368	CcSEcCtD
Cefotaxime—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00357	0.00367	CcSEcCtD
Cefotaxime—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00352	0.00362	CcSEcCtD
Cefotaxime—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00352	0.00362	CcSEcCtD
Cefotaxime—Rash—Formoterol—chronic obstructive pulmonary disease	0.00349	0.00359	CcSEcCtD
Cefotaxime—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00349	0.00359	CcSEcCtD
Cefotaxime—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00348	0.00358	CcSEcCtD
Cefotaxime—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00348	0.00358	CcSEcCtD
Cefotaxime—Headache—Formoterol—chronic obstructive pulmonary disease	0.00346	0.00356	CcSEcCtD
Cefotaxime—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00346	0.00356	CcSEcCtD
Cefotaxime—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00344	0.00354	CcSEcCtD
Cefotaxime—Rash—Montelukast—chronic obstructive pulmonary disease	0.00342	0.00351	CcSEcCtD
Cefotaxime—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00341	0.00351	CcSEcCtD
Cefotaxime—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00341	0.0035	CcSEcCtD
Cefotaxime—Headache—Montelukast—chronic obstructive pulmonary disease	0.00339	0.00349	CcSEcCtD
Cefotaxime—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00335	0.00345	CcSEcCtD
Cefotaxime—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00332	0.00341	CcSEcCtD
Cefotaxime—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00331	0.0034	CcSEcCtD
Cefotaxime—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00329	0.00339	CcSEcCtD
Cefotaxime—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00329	0.00338	CcSEcCtD
Cefotaxime—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00328	0.00338	CcSEcCtD
Cefotaxime—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00328	0.00338	CcSEcCtD
Cefotaxime—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00327	0.00336	CcSEcCtD
Cefotaxime—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00322	0.00331	CcSEcCtD
Cefotaxime—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00318	0.00327	CcSEcCtD
Cefotaxime—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0031	0.00319	CcSEcCtD
Cefotaxime—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00309	0.00317	CcSEcCtD
Cefotaxime—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00308	0.00317	CcSEcCtD
Cefotaxime—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00306	0.00315	CcSEcCtD
Cefotaxime—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.003	0.00308	CcSEcCtD
Cefotaxime—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00295	0.00303	CcSEcCtD
Cefotaxime—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00274	0.00281	CcSEcCtD
Cefotaxime—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00256	0.00263	CcSEcCtD
Cefotaxime—Cefazolin—ALB—chronic obstructive pulmonary disease	0.00252	0.0922	CrCbGaD
Cefotaxime—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00247	0.00254	CcSEcCtD
Cefotaxime—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00247	0.00254	CcSEcCtD
Cefotaxime—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00244	0.00251	CcSEcCtD
Cefotaxime—Malaise—Prednisone—chronic obstructive pulmonary disease	0.0024	0.00247	CcSEcCtD
Cefotaxime—Ceftriaxone—ALB—chronic obstructive pulmonary disease	0.00239	0.0874	CrCbGaD
Cefotaxime—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00238	0.00245	CcSEcCtD
Cefotaxime—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00231	0.00238	CcSEcCtD
Cefotaxime—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00224	0.00231	CcSEcCtD
Cefotaxime—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00221	0.00227	CcSEcCtD
Cefotaxime—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00218	0.00224	CcSEcCtD
Cefotaxime—Shock—Prednisone—chronic obstructive pulmonary disease	0.00214	0.0022	CcSEcCtD
Cefotaxime—Cefalotin—ALB—chronic obstructive pulmonary disease	0.0021	0.0765	CrCbGaD
Cefotaxime—Cephalexin—ALB—chronic obstructive pulmonary disease	0.0019	0.0696	CrCbGaD
Cefotaxime—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00189	0.00194	CcSEcCtD
Cefotaxime—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00189	0.00194	CcSEcCtD
Cefotaxime—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00188	0.00193	CcSEcCtD
Cefotaxime—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00179	0.00184	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00178	0.00183	CcSEcCtD
Cefotaxime—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00178	0.00183	CcSEcCtD
Cefotaxime—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00173	0.00178	CcSEcCtD
Cefotaxime—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00172	0.00177	CcSEcCtD
Cefotaxime—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00172	0.00177	CcSEcCtD
Cefotaxime—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.0016	0.00165	CcSEcCtD
Cefotaxime—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00154	0.00158	CcSEcCtD
Cefotaxime—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00149	0.00153	CcSEcCtD
Cefotaxime—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00138	0.00142	CcSEcCtD
Cefotaxime—Rash—Prednisone—chronic obstructive pulmonary disease	0.00137	0.00141	CcSEcCtD
Cefotaxime—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00137	0.00141	CcSEcCtD
Cefotaxime—Headache—Prednisone—chronic obstructive pulmonary disease	0.00136	0.0014	CcSEcCtD
Cefotaxime—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00129	0.00133	CcSEcCtD
